Search

Author/Creator Frödin, Jan-Erik

1. A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial. (1st February 2016)

Authors:
Ekman, Simon; Harmenberg, Johan; Frödin, Jan-Erik; Bergström, Stefan; Wassberg, Cecilia; Eksborg, Staffan; Larsson, Olle; Axelson, Magnus; Jerling, Markus; Abrahmsen, Lars; Hedlund, Åsa; Alvfors, Carina; Ståhl, Birgitta; Bergqvist, Michael
Journal:
Acta oncologica
Issue:
Volume 55:Number 2(2016)
Page Start:
140
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience. (March 2023)

Authors:
Pedone, Cristiana; Sorcini, Bruno; Staff, Caroline; Färlin, Johanna; Fokstuen, Tone; Frödin, Jan-Erik; Nilsson, Per J.; Martling, Anna; Valdman, Alexander
Journal:
Clinical and translational radiation oncology
Issue:
Volume 39(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Why is intravenous chemotherapy cancelled and how often. Could it be prevented? A prospective analysis of all planned and given intravenous anti-tumor treatments at the Department of Oncology, Karolinska University Hospital, Stockholm during one month. (July 2015)

Authors:
Fuentes, Stina; Frödin, Jan-Erik
Journal:
Acta oncologica
Issue:
Volume 54:Number 7(2015)
Page Start:
1056
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗